A Double-Blind, Placebo-Controlled Randomized Trial to Study the Viaskin Milk Efficacy and Safety for Treating IgE-Mediated Cow's Milk Allergy in Children

Trial Profile

A Double-Blind, Placebo-Controlled Randomized Trial to Study the Viaskin Milk Efficacy and Safety for Treating IgE-Mediated Cow's Milk Allergy in Children

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 21 Dec 2016

At a glance

  • Drugs Food allergy immunotherapy (Primary)
  • Indications Milk hypersensitivity
  • Focus Therapeutic Use
  • Acronyms MILES
  • Sponsors DBV Technologies
  • Most Recent Events

    • 16 Dec 2016 Planned primary completion date changed from 1 Jul 2017 to 1 Jan 2018.
    • 16 Dec 2016 Status changed from recruiting to active, no longer recruiting.
    • 08 Nov 2016 According to DBV Technologies media release, the blinded part of the MILES study is expected to complete in the second half of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top